ArticleEuropean heart journal open2026
Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclines.
Sunnia T Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.